Issued on behalf of Avaí Bio, Inc. VANCOUVER, BC, March 24, 2026 /PRNewswire/ -- USANewsGroup.com — The FDA has approved more than 40 cell and gene therapy products. The regenerative medicine market ...
Researchers from Xi'an Jiaotong-Liverpool University (XJTLU) in China have developed a streamlined process that makes it easier to produce tiny therapeutic particles released by cells, called exosomes ...
Cell and gene therapy developers must build continuity of engagement to create trust in the modalities, according to a report ...
The stem cell therapy market is witnessing strong growth driven by rising demand for regenerative medicine and advanced treatment options for chronic diseases such as cancer, diabetes, and ...
Cell therapy manufacturers approach autologous therapy manufacturing in multiple ways, with point-of-care manufacturing, academic projects embedded within major medical centers, and centralized ...
Two papers published in The New England Journal of Medicine highlight the potential of gene editing for treatment of sickle ...
Kytopen Corp., a leader in non-viral, continuous flow cellular engineering technologies, T-CURX GmbH ("T-CURX"), a leader in transposon-based CAR-T manufacturing, and Fraunhofer IZI, a developer of ...
Oncology pharmacists can operationalize payer-mediated transitions such as biosimilar adoption, minimizing clinician burden while reducing waste and total cost of care. Earlier CAR T-cell therapy ...
Cell therapy is an advanced biomedical approach that utilizes living cells as therapeutic agents to treat disease or repair tissue. 4 Scientists isolate cells from a patient or a healthy donor and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results